AYTU BioPharma, Inc. AYTU Q2 2025 Annual earnings
Reported September 23, 2025 · After market close
Revenue estimate$17.9M
EPS estimate-$0.02
Next report
Sep 22, 2026 (in 2 months)Revenue estimate$17.2M
EPS estimate-$0.22
Versus estimates
Revenue
Diluted EPS
Ask the moment AYTU BioPharma, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did AYTU BioPharma, Inc. report Q2 2025 earnings?
- AYTU BioPharma, Inc. (AYTU) reported Q2 2025 earnings on September 23, 2025 after market close.
- What were AYTU BioPharma, Inc.'s Q2 2025 revenue and EPS?
- AYTU BioPharma, Inc. reported revenue of $15.1M and diluted EPS of $-0.26 for Q2 2025.
- Did AYTU BioPharma, Inc. beat estimates in Q2 2025?
- Revenue missed the consensus estimate of $17.9M by $2.8M. EPS missed the consensus estimate of $-0.02 by $0.24.
- How did AYTU BioPharma, Inc.'s Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 15.8% from $18.0M a year earlier and diluted EPS grew 68.3% from $-0.82.
- Where can I find AYTU BioPharma, Inc.'s Q2 2025 SEC filings?
- You can read the 10-K periodic report (0001437749-25-029723) directly on SEC EDGAR. The filing index links above go to sec.gov.